Product image of Xospata (Gilteritinib) supplied by GNH India

Xospata

Active Ingredient:
Gilteritinib
Origin:
EU

Xospata (Gilteritinib)

Xospata (gilteritinib) is an oral prescription medicine used for treating certain types of acute myeloid leukemia. This overview covers key details about its uses, effects, and safety considerations for informed decision-making.

Manufacturer / TM Owner

Astellas Pharma Europe B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Xospata (gilteritinib) is primarily used to treat adults with relapsed or refractory acute myeloid leukemia (AML) who have a specific genetic mutation called FLT3. It belongs to a class of drugs known as tyrosine kinase inhibitors, which work by blocking signals that promote cancer cell growth. Patients often ask, 'what is gilteritinib used for' when exploring treatment options for AML. It is prescribed when standard treatments have not been effective.

Side Effects

  • Gilteritinib is taken orally and may help slow the progression of AML by targeting cancer cells with the FLT3 mutation. Common effects include fatigue, nausea, and changes in liver enzyme levels. Some patients report gastrointestinal discomfort or skin reactions. These effects vary by individual and should be monitored by a healthcare provider.

Precautions & Warnings

  • Xospata should be handled with care, especially by individuals with known allergies to gilteritinib or its components. Pregnant or breastfeeding individuals should consult a doctor before use due to potential risks. Regular blood tests are recommended to monitor for side effects like low blood cell counts or liver function changes.

Avoid Interactions

  • Gilteritinib may interact with other medications, including strong CYP3A inhibitors or inducers, which can affect its effectiveness or increase side effects. Alcohol and certain herbal supplements may also interact, so it is important to discuss all current medications with a healthcare provider. Grapefruit products should be avoided while taking this medicine.

Frequently Asked Questions

Xospata (gilteritinib) is used to treat adults with relapsed or refractory acute myeloid leukemia (AML) that has a FLT3 mutation.

Xospata is taken orally, typically once daily, as prescribed by a healthcare provider.

Common side effects may include fatigue, nausea, and changes in liver enzymes, though these vary by individual.

Alcohol may interact with gilteritinib; consult your doctor before consuming alcohol.

Xospata may harm an unborn baby; pregnant individuals should discuss risks with their healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Gilteritinib

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT